Kliinisen patologian ja oikeuslääketieteen laitos
Department of Pathology and Forensic Medicine

Julkaisut 1993
Publications 1993

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.


1 Aaltomaa S et al. Demographic prognostic factors in breast cancer.
2 Aaltomaa S et al. Comparison of classic and quantitative prognostic factors in hormone receptor-positive and hormone receptor-negative female breast cancer.
3 Aaltomaa S et al. Predictive value of a morphometric prognostic index (MPI) in female breast cancer.
4 Aaltomaa S et al. The young females have rapidly proliferating breast tumours and unfavorable prognosis.
5 Aaltomaa S et al. Masta cells in breast cancer.
6 Aaltomaa S et al. Proliferating cell nuclear antigen (PC10) immunolabelling and other proliferation indices as prognostic factors in breast cancer.
7 Aaltomaa S et al. Nucleolar organizer regions related to morphometry, flow cytometry, sex steroid receptor content, tumour histology and prognosis in female breast cancer.
8 Aaltomaa S et al. Proliferating cell nuclear antigen (PCNA) immunolabelling as a prognostic factor in axillary lymph node negative breast cancer.
9 Chang F et al. The p53 tumor suppressor gene as a common cellular target in human carcinogenesis.
10 Chang F et al. Screening for human papillomavirus infections in esophageal squamous-cell carcinomas by in situ hybridization.
11 Chang F et al. Demonstration of human papillomavirus (HPV) type 30 in esophageal squamous-cell carcinomas by in situ hybridization.
12 Chang F et al. Tumourigenesis associated with the p53 tumour suppressor gene.
13 Eskelinen M et al. A multiparameter diagnostic score in clinical diagnosis of acute cholecystitis: a prospective study of 1333 patients with acute abdominal pain.
14 Eskelinen M et al. Diagnostic approaches in acute cholecystitis; a prospective study of 1333 patients with acute abdominal pain.
15 Eskelinen M et al. The value of histoquantitative measurements in prognostic assessment of renal adenocarcinoma.
16 Harvima IT et al. Mast cell tryptase and chymase in developing and mature psoriatic lesions.
17 Harvima IT et al. Association of cutaneous mast cells and sensory nerves with psychic stress in psoriasis.
18 Harvima RJ et al. Screening of effects of selenomethionine-enriched yeast supplementation on various immunological and chemical parameters of skin and blood in psoriatic patients.
19 Heinonen O et al. Circulating immune complexes in sera from patients with Alzheimer's disease, multi-infarct dementia and Down's syndrome.
20 Hellberg D et al. Behavior of cervical intraepithelial neoplasia (CIN) associated with various human papillomavirus (HPV) types.
21 Hippeläinen M et al. Mitotic activity index, volume corrected mitotic index and human papilloma-virus suggestive morphology are not prognostic factors in carcinoma of oesophagus.
22 Hippeläinen MI et al. Prevalence and risk factors of genital human papillomavirus (HPV) infections in healthy males. A study on finnish conscripts.
23 Hippeläinen MI et al. Diagnosis of genital human papillomavirus (HPV) lesions in the male: correlation of peniscopy, histology and in situ hybridization.
24 Ho K et al. The genetic drift of human papillomavirus type 16 is a means reconstructing prehistoric viral spread and the movement of ancient human populations.
25 Ji H et al. C-erbB-2 oncogene related to p53 expression, cell proliferation and prognosis in breast cancer.
26 Johansson R, Kellokumpu-Lehtinen P. Syövän hormonihoito ja biologinen hoito. Ajankohtaista syöpätaudeista.
27 Jortikka M et al. A high sensitivity dot-blot assay for proteoglycans by cuprolinic blue precipitation.
28 Kaijalainen S et al. An alternative hot start technique for pcr in small volumes using beads of wax-embedded reaction components dried in trehalose.
29 Karhunen PJ, Servo A. Sudden fatal or non-operable bleeding from ruptured intracranial aneurysm: evaluation by post-mortem angiography with vulcanizing contrast medium.
30 Kataja V et al. Risk factors associated with cervical human papillomavirus infections: a case-control study.
31 Lahtinen H et al. NMDA-sensitive (3H) glutamate binding in the epileptic rat hippocampus: an autoradiographic study.
32 Lahtinen H et al. Long-term alterations in NMDA-sensitive L-(3H) glutamate binding in the rat hippocampus following fimbria-fornix lesioning.
33 Lahtinen H et al. Biochemical and morphological changes in the rat hippocampus following transection of the fimbria-fornix.
34 Lammi M et al. Adaptation of canine femoral head articular cartilage to long distance running exercise in young beagles.
35 Lammi M et al. Proteoglycan biosynthesis in chondrocytes cultures during cyclic or static hydrostatic pressure.
36 Lammi M et al. Sulfate incorporation assay from chondrocyte culture medium by a dot-blot precipitation with safranin O.
37 Lammi MJ et al. Effects of long-distance (40 km/day) running exercise on canine femoral head articular cartilage.
38 Lang S et al. Tumour induction in mouse epidermal cells irradiated by hot particles.
39 Lipponen P. Expression of c-erbB-2 oncoprotein in transitional cell bladder cancer.
40 Lipponen P. Image analysis of Ag-NOR proteins in transitional cell bladder cancer.
41 Lipponen P. The changing importance of prognostic factors in bladder cancer during a long-term follow-up.
42 Lipponen P et al. Nucleolar organizer regions in myofibroblasts in breast cancer. Relation to cancer cell morphometry, flow cytometry, sex steroid receptor content, tumour histology and prognosis.
43 Lipponen P et al. Morphometric quantitation of nucleolar organizer region proteins in breast cancer.
44 Lipponen P, Eskelinen M. Expression of C-50 antigen as a prognostic variable in transitional cell bladder tumours.
45 Lipponen P et al. Expression of the tumour-associated antigen C-242 in transitional cell bladder tumours: a comparison to C-50.
46 Lipponen P et al. Tumour infiltrating lymphocytes as an independent prognostic factor in transitional cell bladder cancer.
47 Lipponen P et al. Prediction of superficial bladder cancer by nuclear image analysis.
48 Lipponen P et al. Grading of superficial bladder cancer by quantitative mitotic frequency analysis.
49 Lipponen P et al. Prognostic factors in nodular transitional cell bladder tumours.
50 Lipponen P et al. Proliferation indices as independent prognostic factors in papillary TA-T1 transitional cell bladder tumours.
51 Lipponen P et al. Clinical prognostic factors in transitional cell cancer of the bladder.
52 Lipponen P et al. p53 protein expression in breast cancer as related to histopathological characteristics and prognosis.
53 Lipponen P et al. Flow cytometry in comparison with mitotic index in predicting disease outcome in transitional-cell bladder cancer.
54 Lipponen PK. Interrelationship between expression of p53, proliferating cell nuclear antigen and c-erbB-2 in bladder cancer.
55 Lipponen PK. Overexpression of p53 nuclear oncoprotein in transitional cell bladder and it's prognostic value.
56 Lipponen PK. Stereologically measured nuclear volume in comparison to two dimensional nuclear morphometry, mitotic index and flow cytometry in pedicting disease outcome in bladder cancer.
57 Lipponen PK. The prognostic value of basement membrane morphology, tumour histology and morphometry in superficial bladder cancer.
58 Miettinen R et al. Persisting axonal degeneration in the hippocampus after transection of the fimbria-fornix.
59 Miettinen R et al. Neocortical, hippocampal and septal parvalbumin- and somatostatin-containing neurons in young and aged rats: correlation with passive avoidance and water maze performance.
60 Mäkinen K et al. Nucleolar organiser regions as prognostic factors in pancreatic adenocarcinoma.
61 Mäkinen K et al. Ag-NORs related to flow cytometry, morphometry and prognosis in patients with pancreatic cancer.
62 Mälkki Y et al. Effects of oat-bran concentrate on rat serum lipids and liver fat infiltration.
63 Naukkarinen A et al. Immunohistochemical analysis of sensory nerves and neuropeptides, and their contacts with mast cells in developing and mature psoriatic lesions.
64 Parkkinen J. Loading influences on proteoglycan synthesis in cultured articular cartilage and chondrocytes.
65 Parkkinen J et al. Effects of cyclic hydrostatic pressure on proteoglycan synthesis in cultured chondrocytes and articular cartilage explants.
66 Parkkinen J et al. Altered Golgi apparatus in hydrostatically loaded articular cartilage chondrocytes.
67 Parkkinen J et al. Hydrostatic pressure modulates the organization of the cytoskeleton and golgi apparatus in cultured chondrocytes.
68 Pasanen P et al. Pancreatic lymphoma.
69 Pennanen S et al. Effects of 2-ethylhexanoic acid on reproduction and postnatal development in wistar rats.
70 Rihkanen H et al. Human papillomavirus in laryngeal papillomas and in adjacent normal epithelium.
71 Savolainen V et al. Moderate alcohol consumption and alcoholic liver disease - evidence of a threshold level of effects of alcohol.
72 Syrjänen K. Human papillomavirus and squamous cell carcinogenesis.
73 Syrjänen K. Histology of genital papillomavirus infection.
74 Tervahauta AI et al. Expression of p53 protein related to the presence of human papillomavirus (HPV) DNA in genital carcinomas and precancer lesions.
75 The Condylomata International Collaborative Study Group (Syrjänen K, Syrjänen S). Randomized placebo-controlled double-blind combined therapy with laser surgery and systemic interferon-alpha-2a in the treatment of anogenital condylomata acuminatum.
76 The Condylomata International Collaborative Study Group (Syrjänen K, Syrjänen S). Recurrent condylomata acuminata treated with recombinant interferon alpha-2a. A multicenter double-blind placebo-controlled clinical trial.
77 Tosi P et al. Use of antibodies against a synthetic peptide of the E6 protein of human papillomavirus (HPV) type 16 for the diagnosis of genital HPV lesions.
78 Tuomisto J et al. Cancer risk of mutagenic acids in chlorinated drinking water.
79 Williams DM et al. Classification and diagnostic criteria for oral lesions in HIV infection.

Kliinisen patologian ja oikeuslääketieteen laitos Department of Pathology and Forensic Medicine
Julkaisutietokanta 15.4.2008 Publications Data Base 15.4.2008